{"id":"https://openalex.org/W2040192775","doi":"https://doi.org/10.1007/s10637-015-0220-z","title":"Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors","display_name":"Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors","publication_year":2015,"publication_date":"2015-02-20","ids":{"openalex":"https://openalex.org/W2040192775","doi":"https://doi.org/10.1007/s10637-015-0220-z","mag":"2040192775","pmid":"https://pubmed.ncbi.nlm.nih.gov/25698442"},"language":"en","primary_location":{"id":"doi:10.1007/s10637-015-0220-z","doi":"https://doi.org/10.1007/s10637-015-0220-z","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10637-015-0220-z","pdf_url":null,"source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005732386","display_name":"Sarah A. Holstein","orcid":"https://orcid.org/0000-0002-9342-5635","observed_orcids":["https://orcid.org/0000-0002-9342-5635"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sarah A. Holstein","raw_affiliation_strings":["Department of Medicine, Roswell Park Cancer Institute, Elm & Carlton Sts, Buffalo, NY, 14263, USA, sarah.holstein@roswellpark.org","Roswell Park Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Roswell Park Cancer Institute, Elm & Carlton Sts, Buffalo, NY, 14263, USA, sarah.holstein@roswellpark.org","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"Roswell Park Cancer Institute","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113725441","display_name":"James C. Bigelow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I106969075","display_name":"Idaho State University","ror":"https://ror.org/0162z8b04","country_code":"US","type":"education","lineage":["https://openalex.org/I106969075"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James C. Bigelow","raw_affiliation_strings":["Idaho State University, Pocatello, ID, USA","Idaho State University#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Idaho State University, Pocatello, ID, USA","institution_ids":["https://openalex.org/I106969075"]},{"raw_affiliation_string":"Idaho State University#TAB#","institution_ids":["https://openalex.org/I106969075"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002348205","display_name":"Richard D. Olson","orcid":"https://orcid.org/0000-0002-2827-2142","observed_orcids":["https://orcid.org/0000-0002-2827-2142"]},"institutions":[{"id":"https://openalex.org/I4210150757","display_name":"Gem Pharmaceuticals (United States)","ror":"https://ror.org/043cevr52","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard D. Olson","raw_affiliation_strings":["Gem Pharmaceuticals, LLC, Birmingham, AL, USA","Gem Pharmaceuticals, LLC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gem Pharmaceuticals, LLC, Birmingham, AL, USA","institution_ids":["https://openalex.org/I4210150757"]},{"raw_affiliation_string":"Gem Pharmaceuticals, LLC","institution_ids":["https://openalex.org/I4210150757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113572193","display_name":"Robert E. Vestal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150757","display_name":"Gem Pharmaceuticals (United States)","ror":"https://ror.org/043cevr52","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert E. Vestal","raw_affiliation_strings":["Gem Pharmaceuticals, LLC, Birmingham, AL, USA","Gem Pharmaceuticals, LLC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gem Pharmaceuticals, LLC, Birmingham, AL, USA","institution_ids":["https://openalex.org/I4210150757"]},{"raw_affiliation_string":"Gem Pharmaceuticals, LLC","institution_ids":["https://openalex.org/I4210150757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075332653","display_name":"Gerald M. Walsh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150757","display_name":"Gem Pharmaceuticals (United States)","ror":"https://ror.org/043cevr52","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerald M. Walsh","raw_affiliation_strings":["Gem Pharmaceuticals, LLC, Birmingham, AL, USA","Gem Pharmaceuticals, LLC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gem Pharmaceuticals, LLC, Birmingham, AL, USA","institution_ids":["https://openalex.org/I4210150757"]},{"raw_affiliation_string":"Gem Pharmaceuticals, LLC","institution_ids":["https://openalex.org/I4210150757"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112117936","display_name":"Raymond J. Hohl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268258","display_name":"Penn State Cancer Institute","ror":"https://ror.org/00bzx1854","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4405268258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raymond J. Hohl","raw_affiliation_strings":["Penn State Hershey Cancer Institute, Hershey, PA, USA","Penn State Hershey Cancer Institute, Hershey, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Penn State Hershey Cancer Institute, Hershey, PA, USA","institution_ids":["https://openalex.org/I4405268258"]},{"raw_affiliation_string":"Penn State Hershey Cancer Institute, Hershey, USA,","institution_ids":["https://openalex.org/I4405268258"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5005732386"],"corresponding_institution_ids":["https://openalex.org/I1292894508"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":null,"fwci":0.918,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.77619938,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"33","issue":"3","first_page":"594","last_page":"602"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.5849999785423279,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.5849999785423279,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.3564000129699707,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.024399999529123306,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anthracycline-derivatives","display_name":"anthracycline derivatives","score":0.8309999704360962},{"id":"https://openalex.org/keywords/doxorubicin-analogs","display_name":"doxorubicin analogs","score":0.9179999828338623},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.800000011920929},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9200000166893005},{"id":"https://openalex.org/keywords/metastatic-solid-tumors","display_name":"metastatic solid tumors","score":0.7710000276565552},{"id":"https://openalex.org/keywords/cardiotoxicity-prevention","display_name":"cardiotoxicity prevention","score":0.8560000061988831},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9729999899864197},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.3149999976158142}],"concepts":[{"id":"https://openalex.org/C2778233292","wikidata":"https://www.wikidata.org/wiki/Q2118956","display_name":"Cardiotoxicity","level":3,"score":0.876788854598999},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7564961910247803},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7375676035881042},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7187488079071045},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.6289058923721313},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5921701192855835},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5825114250183105},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5569149851799011},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5214219093322754},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.4375113248825073},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.3589780330657959},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3543774485588074},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.34845006465911865},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3347601890563965},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2981414496898651},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.11155179142951965}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D003710","descriptor_name":"Demography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D013318","descriptor_name":"Stroke Volume","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018943","descriptor_name":"Anthracyclines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018943","descriptor_name":"Anthracyclines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018943","descriptor_name":"Anthracyclines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018943","descriptor_name":"Anthracyclines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s10637-015-0220-z","doi":"https://doi.org/10.1007/s10637-015-0220-z","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10637-015-0220-z","pdf_url":null,"source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},{"id":"pmid:25698442","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25698442","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational new drugs","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W1492360552","https://openalex.org/W1520073491","https://openalex.org/W1585518597","https://openalex.org/W1828224642","https://openalex.org/W1967378899","https://openalex.org/W1974482337","https://openalex.org/W1982411138","https://openalex.org/W1990164343","https://openalex.org/W1992437129","https://openalex.org/W1998838410","https://openalex.org/W2003225109","https://openalex.org/W2029587579","https://openalex.org/W2034113803","https://openalex.org/W2036336400","https://openalex.org/W2045485835","https://openalex.org/W2049129583","https://openalex.org/W2049755195","https://openalex.org/W2051909138","https://openalex.org/W2055622315","https://openalex.org/W2056441912","https://openalex.org/W2066908594","https://openalex.org/W2068193028","https://openalex.org/W2070005495","https://openalex.org/W2073912429","https://openalex.org/W2091153064","https://openalex.org/W2112351355","https://openalex.org/W2119544587","https://openalex.org/W2132122697","https://openalex.org/W2142195688","https://openalex.org/W2155765426","https://openalex.org/W2158325136","https://openalex.org/W2163151049","https://openalex.org/W2163331945","https://openalex.org/W2169203358"],"related_works":["https://openalex.org/W2600888237","https://openalex.org/W2889884493","https://openalex.org/W2941106257","https://openalex.org/W2528310625","https://openalex.org/W2761743626","https://openalex.org/W2014084640","https://openalex.org/W2156830268","https://openalex.org/W1992437129","https://openalex.org/W2147186048","https://openalex.org/W2887708131"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}